- About
- Strategic Plan
- Structure
- Governance
- Scientific divisions
- ACRF Cancer Biology and Stem Cells
- ACRF Chemical Biology
- Advanced Technology and Biology
- Bioinformatics
- Blood Cells and Blood Cancer
- Clinical Translation
- Epigenetics and Development
- Immunology
- Infectious Diseases and Immune Defence
- Inflammation
- Personalised Oncology
- Population Health and Immunity
- Structural Biology
- Ubiquitin Signalling
- Laboratory operations
- Funding
- Annual reports
- Human research ethics
- Scientific integrity
- Institute life
- Career opportunities
- Business Development
- Collaborators
- Suppliers
- Publications repository
- Awards
- Discoveries
- Centenary 2015
- History
- Contact us
- Research
- Diseases
- Cancer
- Development and ageing
- Immune health and infection
- Research fields
- Research technologies
- Research centres
- People
- Alistair Brown
- Anne-Laure Puaux
- Assoc Prof Joanna Groom
- Associate Profesor Ian Majewski
- Associate Professor Aaron Jex
- Associate Professor Andrew Webb
- Associate Professor Chris Tonkin
- Associate Professor Diana Hansen
- Associate Professor Edwin Hawkins
- Associate Professor Ethan Goddard-Borger
- Associate Professor Gemma Kelly
- Associate Professor Grant Dewson
- Associate Professor Isabelle Lucet
- Associate Professor James Vince
- Associate Professor Jason Tye-Din
- Associate Professor Jeff Babon
- Associate Professor Joan Heath
- Associate Professor John Wentworth
- Associate Professor Justin Boddey
- Associate Professor Kate Sutherland
- Associate Professor Kelly Rogers
- Associate Professor Marie-Liesse Asselin-Labat
- Associate Professor Melissa Call
- Associate Professor Misty Jenkins
- Associate Professor Nawaf Yassi
- Associate Professor Oliver Sieber
- Associate Professor Rachel Wong
- Associate Professor Rhys Allan
- Associate Professor Rosie Watson
- Associate Professor Ruth Kluck
- Associate Professor Shalin Naik
- Associate Professor Sumitra Ananda
- Associate Professor Tim Thomas
- Associate Professor Tracy Putoczki
- Chela Niall
- Deborah Carr
- Dr Alisa Glukhova
- Dr Anna Coussens
- Dr Ashley Ng
- Dr Belinda Phipson
- Dr Ben Tran
- Dr Bernhard Lechtenberg
- Dr Brad Sleebs
- Dr Drew Berry
- Dr Gwo Yaw Ho
- Dr Hamish King
- Dr Hui-Li Wong
- Dr Jacqui Gulbis
- Dr Jim Whittle
- Dr Lucy Gately
- Dr Margaret Lee
- Dr Mary Ann Anderson
- Dr Maryam Rashidi
- Dr Matthew Call
- Dr Nadia Davidson
- Dr Nadia Kershaw
- Dr Philippe Bouillet
- Dr Rebecca Feltham
- Dr Rory Bowden
- Dr Samir Taoudi
- Dr Sarah Best
- Dr Saskia Freytag
- Dr Shabih Shakeel
- Dr Sheau Wen Lok
- Dr Stephin Vervoort
- Dr Yunshun Chen
- Guillaume Lessene
- Helene Martin
- Joh Kirby
- Kaye Wycherley
- Keely Bumsted O'Brien
- Mr Simon Monard
- Mr Steve Droste
- Ms Carolyn MacDonald
- Professor Alan Cowman
- Professor Andreas Strasser
- Professor Andrew Roberts
- Professor Anne Voss
- Professor Clare Scott
- Professor Daniel Gray
- Professor David Huang
- Professor David Komander
- Professor David Vaux
- Professor Doug Hilton
- Professor Geoff Lindeman
- Professor Gordon Smyth
- Professor Ian Wicks
- Professor Ivo Mueller
- Professor James McCarthy
- Professor James Murphy
- Professor Jane Visvader
- Professor Jeanne Tie
- Professor Jerry Adams
- Professor John Silke
- Professor Ken Shortman
- Professor Leanne Robinson
- Professor Leonard C Harrison
- Professor Lynn Corcoran
- Professor Marnie Blewitt
- Professor Matthew Ritchie
- Professor Melanie Bahlo
- Professor Melissa Davis
- Professor Mike Lawrence
- Professor Nicos Nicola
- Professor Peter Colman
- Professor Peter Czabotar
- Professor Peter Gibbs
- Professor Phil Hodgkin
- Professor Sandra Nicholson
- Professor Sant-Rayn Pasricha
- Professor Seth Masters
- Professor Stephen Nutt
- Professor Suzanne Cory
- Professor Terry Speed
- Professor Tony Papenfuss
- Professor Wai-Hong Tham
- Professor Warren Alexander
- Diseases
- Education
- PhD
- Honours
- Masters
- Clinician-scientist training
- Undergraduate
- Student research projects
- A multi-pronged approach to targeting myeloproliferative neoplasms
- A new paradigm of machine learning-based structural variant detection
- A whole lot of junk or a treasure trove of discovery?
- Advanced imaging interrogation of pathogen induced NETosis
- Analysing the metabolic interactions in brain cancer
- Atopic dermatitis causes and treatments
- Boosting the efficacy of immunotherapy in lung cancer
- Building a cell history recorder using synthetic biology for longitudinal patient monitoring
- Characterisation of malaria parasite proteins exported into infected liver cells
- Deciphering the heterogeneity of the tissue microenvironment by multiplexed 3D imaging
- Defining the mechanisms of thymic involution and regeneration
- Delineating the molecular and cellular origins of liver cancer to identify therapeutic targets
- Developing computational methods for spatial transcriptomics data
- Developing drugs to block malaria transmission
- Developing models for prevention of hereditary ovarian cancer
- Developing statistical frameworks for analysing next generation sequencing data
- Development and mechanism of action of novel antimalarials
- Development of novel RNA sequencing protocols for gene expression analysis
- Discoveries in red blood cell production and function
- Discovering epigenetic silencing mechanisms in female stem cells
- Discovery and targeting of novel regulators of transcription
- Dissecting host cell invasion by the diarrhoeal pathogen Cryptosporidium
- Dissecting mechanisms of cytokine signalling
- Doublecortin-like kinases, drug targets in cancer and neurological disorders
- Epigenetic biomarkers of tuberculosis infection
- Epigenetics – genome wide multiplexed single-cell CUT&Tag assay development
- Exploiting cell death pathways in regulatory T cells for cancer immunotherapy
- Exploiting the cell death pathway to fight Schistosomiasis
- Finding treatments for chromatin disorders of intellectual disability
- Functional epigenomics in human B cells
- How do nutrition interventions and interruption of malaria infection influence development of immunity in sub-Saharan African children?
- Human lung protective immunity to tuberculosis
- Improving therapy in glioblastoma multiforme by activating complimentary programmed cell death pathways
- Innovating novel diagnostic tools for infectious disease control
- Integrative analysis of single cell RNAseq and ATAC-seq data
- Interaction with Toxoplasma parasites and the brain
- Interactions between tumour cells and their microenvironment in non-small cell lung cancer
- Investigation of a novel cell death protein
- Malaria: going bananas for sex
- Mapping spatial variation in gene and transcript expression across tissues
- Mechanisms of Wnt secretion and transport
- Multi-modal computational investigation of single-cell communication in metastatic cancer
- Nanoparticle delivery of antibody mRNA into cells to treat liver diseases
- Naturally acquired immune response to malaria parasites
- Organoid-based discovery of new drug combinations for bowel cancer
- Organoid-based precision medicine approaches for oral cancer
- Removal of tissue contaminations from RNA-seq data
- Reversing antimalarial resistance in human malaria parasites
- Role of glycosylation in malaria parasite infection of liver cells, red blood cells and mosquitoes
- Screening for novel genetic causes of primary immunodeficiency
- Single-cell ATAC CRISPR screening – Illuminate chromatin accessibility changes in genome wide CRISPR screens
- Spatial single-cell CRISPR screening – All in one screen: Where? Who? What?
- Statistical analysis of single-cell multi-omics data
- Structural and functional analysis of epigenetic multi-protein complexes in genome regulation
- Structural basing for Wnt acylation
- Structure, dynamics and impact of extra-chromosomal DNA in cancer
- Targeted deletion of disease-causing T cells
- Targeting cell death pathways in tissue Tregs to treat inflammatory diseases
- The cellular and molecular calculation of life and death in lymphocyte regulation
- The role of hypoxia in cell death and inflammation
- The role of ribosylation in co-ordinating cell death and inflammation
- Understanding Plasmodium falciparum invasion of red blood cells
- Understanding cellular-cross talk within a tumour microenvironment
- Understanding the genetics of neutrophil maturation
- Understanding the roles of E3 ubiquitin ligases in health and disease
- Unveiling the heterogeneity of small cell lung cancer
- Using combination immunotherapy to tackle heterogeneous brain tumours
- Using intravital microscopy for immunotherapy against brain tumours
- Using nanobodies to understand malaria invasion and transmission
- Using structural biology to understand programmed cell death
- Validation and application of serological markers of previous exposure to malaria
- School resources
- Frequently asked questions
- Student profiles
- Abebe Fola
- Andrew Baldi
- Anna Gabrielyan
- Ashley Weir
- Bridget Dorizzi
- Casey Ah-Cann
- Catia Pierotti
- Emma Nolan
- Huon Wong
- Jasmine Rou
- Jing Deng
- Joy Liu
- Kaiseal Sarson-Lawrence
- Komal Patel
- Krishneel Prasa
- Lilly Backshell
- Malvika Kharbanda
- Megan Kent
- Naomi Jones
- Pailene Lim
- Rebecca Delconte
- Roberto Bonelli
- Rune Larsen
- Runyu Mao
- Sarah Garner
- Simona Seizova
- Sophie Collard
- Wayne Cawthorne
- Wil Lehmann
- Yanxiang Meng
- Zhong Yan Gan
- Miles Horton
- Alexandra Gurzau
- Student achievements
- Student association
- Learning Hub
- News
- Donate
- Online donation
- Ways to support
- Support outcomes
- Supporter stories
- Rotarians against breast cancer
- A partnership to improve treatments for cancer patients
- 20 years of cancer research support from the Helpman family
- A generous gift from a cancer survivor
- A generous vision for impactful medical research
- A gift to support excellence in Australian medical research
- An enduring friendship
- Anonymous donor helps bridge the 'valley of death'
- Philanthropy through the power of sisterhood
- Renewed support for HIV eradication project
- Searching for solutions to muscular dystrophy
- Supporting research into better treatments for colon cancer
- Taking a single cell focus with the DROP-seq
- Donors
- WEHI.TV
Infection

Infections from viruses, bacteria, fungi and parasites are significant causes of worldwide illness and death.
Our researchers investigate many significant infectious agents with the goal of reducing the global burden of infectious disease.
Our infectious disease research
Our researchers are working to develop better ways to prevent, diagnose and treat infectious diseases. Infections we study include:
- Viral diseases, such as hepatitis B, HIV and influenza.
- Bacterial diseases, such as tuberculosis.
- Fungal diseases, such as cryptococcosis.
- Parasitic diseases, such as malaria, toxoplasmosis and scabies.
Our research into particular infectious diseases is closely integrated with investigations into how our immune system responds to that disease. This is contributing to:
- Advancing vaccine development to generate immune responses that prevent infections.
- New strategies to treat infections through manipulating our immune response.
What are infections?
We are constantly exposed to many different types of living organisms in our environment. A small proportion of these are able to invade our body and live within us. When an invading organism makes us sick, this is termed an infection.
In some cases, organisms living within us are beneficial to our health. For example, many bacteria living in our bowel are important for digestion and are a source of certain vitamins. These ‘friendly’ organisms can also impede the entry of disease-causing infectious organisms.
Types of infectious organisms
A diversity of living organisms has developed the ability to live within our bodies. The broad classes of these include:
- Viruses, small particles that enclose a viral genome that must reproduce within cells.
- Bacteria, simple cells that can often divide rapidly.
- Fungi, more complex cells or branching strands of cells.
- Parasites, a broad term for organisms that invade our body that are not any of the above classes. They can include single-cell ‘protists’, and parasitic animals such as parasitic worms, and parasitic mites.
Organisms that are only visible using a microscope, such as viruses, bacteria and many fungi and single cell parasites, are often called ‘microbes’.
Infections can occur in many different parts of our body. Some organisms, such as the scabies mite, invade only a few millimetres into the outer layers of our skin. Viruses can only grow and reproduce within cells.
Some bacteria, fungi and parasites also grow within cells. Others can live within certain tissues in our body, or in cavities such as our lungs or mouth. Some diseases can occur without direct contact with the microbe, such as illness caused by toxins released by bacteria into foods.
How do infections make us sick?
There are many different ways that infectious agents make us sick. These include:
- Damaging cells or tissues within our body directly, such as a virus killing its host cell.
- Secreting toxins that damage cells.
- Forcing cells to behave abnormally, such as dividing uncontrollably.
- Competing for nutrients or other resources with our own cells.
- Physically obstructing the normal function of an organ.
- Triggering harmful immune responses or inflammation.
The immune response is critical to prevent infections spreading. People with immunodeficiencies may not mount an appropriate immune response and can suffer overwhelming illness from microbes that normally cause mild or no infection.
The symptoms of an infection can be caused by:
- The infectious agent itself, or toxins it releases.
- The immune response to that infection, especially inflammatory responses
The duration of an infection can vary. An infection can be:
- Acute, meaning the infectious agent is soon removed, although the damage it causes may take longer to resolve.
- Chronic, meaning the infectious organism persists within our body long-term, avoiding immune clearance.
Some infections are chronic, but periodically reappear in an acute form.
Evading the immune system
Our immune system protects us from many infections. However, some infectious organisms have developed strategies to evade our immune defenses. These can include:
- Changing proteins on their surface (or the surface of an infected cell) to evade specific immune responses.
- Hiding within cells.
- Producing a dormant form that can re-awaken when host immunity is weakened.
- Residing in parts of the body that are poorly accessed by the immune system, such as the skin surface or brain.
Our researchers are discovering how particular infectious organisms evade immune detection. This is revealing new strategies for enhancing the immune response to clear the infection, and also new approaches to designing vaccines to prevent infection.
How are infections prevented?
Two important ways to prevent contacting an infectious disease are:
- Avoiding exposure to the infectious agent, such as avoiding mosquito bites to prevent malaria, and washing hands to reduce the spread of influenza.
- Inducing a protective immune response, such as through vaccination, that prevents the infection establishing.
The smallpox virus was the first infection to be completely eliminated from humans worldwide, aided by a global vaccination program. Our researchers aspire to contribute to the elimination of other infections, particularly malaria.
How are infections treated?
The ideal treatments for infections kill the infectious agent without harming the body’s own cells. Many treatments target molecular differences between microbes and humans.
The broad classes of medicines used to treat infections are:
- Antivirals
- Antibiotics, to treat bacterial infections
- Antifungals
- Antiparasitics
Our researchers are investigating many new approaches to treating disease. An important focus is to identify molecules unique to an infectious agent that can be targeted by new medicines developed using medicinal chemistry.
Our researchers are also developing new approaches to treating infections, particularly chronic infections, by boosting the immune response to the infectious agent.
For some infectious diseases, treatments also involve reversing or resolving the damage caused by the infection. For example, people with gastrointestinal infections who are dehydrated are given additional fluids.
Drug resistance
As infectious organisms proliferate, some acquire genetic changes. Occasionally these allow an organism to become resistant to a particular treatment. When that treatment is given, the resistant microbes can continue to grow in our bodies, replacing the treatment-sensitive organisms. Resistance is more likely to develop when people do not take a full course of treatment, such as an antibiotic course.
Over time a drug-resistant strain of a disease can become the predominant strain in the community. When more than one type of treatment for an infection is available, a strain of microbes resistant to one treatment may be sensitive to another.
Over time, multi-drug resistance can develop, rendering many treatments ineffective. Increasing rates of multi-drug resistance are limiting the options for treating many types of infection, including malaria and tuberculosis.
Our researchers aim to develop new treatments for infections using approaches that minimise the likelihood of resistance developing. By investigating the basic biology of infections, they are revealing how drug resistance occurs, and designing treatment strategies that are more difficult to evade.
Treatments that boost the immune system’s clearance of infections are another approach that may overcome problems posed by multidrug resistant infections.
Researchers:
The institute's malaria research team is homing in on a new target for malaria treatment
Visualisation of the parasite infection inside a pregnant female mosquito.
Professor Marc Pellegrini discusses the threat of antibiotic resistant bacteria.
International health officials recently warned of a “catastrophic threat” to human health, given one of the last remaining antibiotics capable of defeating superbugs – carbapenem antibiotics – is succumbing to the deadly bacteria.
An overview of malaria research and progress to date, including vaccine and drug development, and our research in malaria-endemic countries.
Our research has revealed an unanticipated secret about the cells that form the first line of defence in the body’s fight against infection